...
首页> 外文期刊>Frontiers in Molecular Biosciences >Next-Generation Molecular Diagnostics Development by CRISPR/Cas Tool: Rapid Detection and Surveillance of Viral Disease Outbreaks
【24h】

Next-Generation Molecular Diagnostics Development by CRISPR/Cas Tool: Rapid Detection and Surveillance of Viral Disease Outbreaks

机译:CRISPR / CAS工具的下一代分子诊断开发:快速检测和病毒疾病爆发的监测

获取原文

摘要

Virus disease spread effortlessly mechanically or through minute insect vectors which are extremely challenging to avoid. Emergence and re-emergence of new viruses such as SARS-CoV-2, H1N1 influenza virus, Avian influenza virus, dengue virus, Citrus tristeza virus, Tomato yellow leaf curl virus, have paralyzed the economy of many countries. The cure for major viral diseases is not feasible; however, early detection and surveillance of the disease can obstruct their spread. Therefore, advances in the field of virus diagnosis and the development of new Point-of-care testing kits become necessary globally. CRISPR/ Cas is an emerging technology for gene editing and diagnostics development. Several rapid nucleic acid diagnostic kits have been developed and validated using Cas9, Cas12, and Cas13 proteins. This review summarises the CRISPR/Cas based next-generation molecular diagnostic techniques and portability of devices for field-based utilization.
机译:病毒疾病毫不费力地展开或通过微小的昆虫载体传播,这极其挑战以避免。 SARS-COV-2,H1N1流感病毒,禽流感病毒,登革热病毒,柑橘Tristeza病毒,番茄黄叶卷曲病毒等新病毒的出现和重新出现,如番茄黄叶卷曲病毒,瘫痪了许多国家的经济。主要病毒疾病的治疗是不可行的;然而,早期发现和对疾病的监测可以阻碍它们的蔓延。因此,对病毒诊断领域的进步和新的护理点测试套件的发展成为全球必不可少的。 CRISPR / CAS是一种用于基因编辑和诊断开发的新兴技术。使用Cas9,Cas12和Cas13蛋白已经开发并验证了几种快速核酸诊断试剂盒。本综述总结了基于CROP / CA的下一代分子诊断技术和用于基于现场利用的设备的可移植性。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号